vanzacaftor, tezacaftor, and deutivacaftor
vanzacaftor, tezacaftor, and deutivacaftor · TEZACAFTOR 20 mg/1; VANZACAFTOR 4 mg/1; DEUTIVACAFTOR 50 mg/1 · Tablet, Film Coated · Patheon Pharmaceuticals Inc.
NDC 67651-0396-00 · 63084 TABLET, FILM COATED in 1 DRUM · DRUG FOR FURTHER PROCESSING · View full market →
Bulk ingredient — not a finished product
This NDC is a raw material (drug for further processing) sold to drug manufacturers or compounders, not a product pharmacies dispense. Retail pricing, TE codes, fragility scores, and shortage reports don't apply to bulk listings — those attach to finished products made from this ingredient.
Medicare Part D
This is a bulk ingredient, not a dispensable product — it is a raw material sold to manufacturers and compounders, so no plan prices it.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Regulatory
- Application
- —
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- —
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of vanzacaftor, tezacaftor, and deutivacaftor (Tablet, Film Coated)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Patheon Pharmaceuticals Inc. | TEZACAFTOR 50 mg/1; VANZACAFTOR 10 mg/1; DEUTIVACAFTOR 125 mg/1 | Aug 20, 2026 | Sep 3, 2026 |
| Patheon Pharmaceuticals Inc. | TEZACAFTOR 20 mg/1; VANZACAFTOR 4 mg/1; DEUTIVACAFTOR 50 mg/1 | Aug 20, 2026 | Sep 3, 2026 |
| Vertex Pharmaceuticals Incorporated | VANZACAFTOR 4 mg/1; TEZACAFTOR 20 mg/1; DEUTIVACAFTOR 50 mg/1 | Aug 26, 2026 | Sep 2, 2026 |
| Vertex Pharmaceuticals Incorporated | VANZACAFTOR 10 mg/1; TEZACAFTOR 50 mg/1; DEUTIVACAFTOR 125 mg/1 | Aug 26, 2026 | Sep 2, 2026 |
| Patheon Pharmaceuticals Inc. | TEZACAFTOR 50 mg/1; VANZACAFTOR 20 mg/1; DEUTIVACAFTOR 4 mg/1 | Jul 22, 2026 | Aug 19, 2026 |
| Patheon Pharmaceuticals Inc. | TEZACAFTOR 125 mg/1; VANZACAFTOR 50 mg/1; DEUTIVACAFTOR 10 mg/1 | Jul 22, 2026 | Aug 19, 2026 |
| Vertex Pharmaceuticals Incorporated | VANZACAFTOR 50 mg/1; TEZACAFTOR 20 mg/1; DEUTIVACAFTOR 4 mg/1 | Jul 22, 2026 | Aug 19, 2026 |
| Vertex Pharmaceuticals Incorporated | VANZACAFTOR 125 mg/1; TEZACAFTOR 50 mg/1; DEUTIVACAFTOR 10 mg/1 | Jul 22, 2026 | Aug 19, 2026 |
| Patheon Pharmaceuticals Inc. | DEUTIVACAFTOR 50 mg/1; TEZACAFTOR 20 mg/1; VANZACAFTOR 4 mg/1 | Jul 15, 2026 | Jul 15, 2026 |
| Patheon Pharmaceuticals Inc. | DEUTIVACAFTOR 125 mg/1; TEZACAFTOR 50 mg/1; VANZACAFTOR 10 mg/1 | Jul 15, 2026 | Jul 15, 2026 |
| Vertex Pharmaceuticals Incorporated | DEUTIVACAFTOR 125 mg/1; TEZACAFTOR 50 mg/1; VANZACAFTOR 10 mg/1 | Jul 15, 2026 | Jul 15, 2026 |
| Vertex Pharmaceuticals Incorporated | DEUTIVACAFTOR 50 mg/1; TEZACAFTOR 20 mg/1; VANZACAFTOR 4 mg/1 | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "vanzacaftor, tezacaftor, and deutivacaftor — NDC 67651-0396-00," retrieved September 3, 2026, https://drugdashboards.com/drug/67651039600.
Free to cite with attribution — see how the data is put together.